A manufacturer of skin care and care -based in New Jersey is voluntarily removed multiple types of manual soap, cleaner and antiseptic products due to bacteria pollution.
Dermarite Industries, LLC announced a retirement of its Dermakleen antiseptic lotion soap with vitamin E in sizes of 1,000 milliliters and 800 milliliters, as well as Kleenfoam antibacterial foam soap with aloe vera (1,000 milliliters), the external analgesic of Dermasarra (the sizes of 7.5) and the perigiene flood (7.5-satser) They admonished), all who piled up), all who piled up), all who piled up), which was one of those who pile up), all who were admonished), of which they are treated), of which they are cleaned). and Puerto Rico.
The affected products have expiration dates that range from July 2025 to February 2027. A complete list of lot numbers and affected reorders can be found here.
The company’s retirement announcement, dated August 8, was also shared in the FOOD AND MEDICINE ADMINISTRATION OF USA. Website during the weekend.
Dermarite said in his announcement that the affected products are contaminated with Burkholderia Cepacia, a type of bacteria that can cause serious or potentially fatal infections.
Dermarite Industries, LLC is voluntarily withdrawing many individual products in the table below due to microbial contamination identified as Burkholderia Cepecia.
FDA
Dermarite Industries, LLC is voluntarily withdrawing many individual products in the table below due to microbial contamination identified as Burkholderia Cepecia.
FDA
“Contaminated products can be used by immunosuppressed individuals or by people who attend immunosuppressed individuals,” said Dermite. “In healthy individuals with minor skin lesions, the use of the product will probably result in local infections, while in immunocompromised individuals the infection is more likely to spread in the bloodstream that leads to potentially deadly sepsis.”
He Centers for Disease Control and Prevention It establishes that Burkholderia Cepacia, also known as B. Cepacia or BCC, is often spread through soil and water sources, in addition to surfaces and contaminated products and through the contact from person to person.
When someone is infected with the bacteria, it may not exhibit any symptoms. If they show symptoms, they may experience respiratory problems or fever or fatigue.
People who are immunocompromised or those with chronic pulmonary conditions, including cystic fibrosis, have a greater risk of infected with B. Cepacia, according to CDC.
Bacteria can also be resistant to antibiotics, which makes infections difficult to treat, according to CDC.
Dermarite said that he has already notified his distributors and customers by email “to immediately examine the available inventory” and destroy any retired product “according to the process of each installation.”
The company said it has not received any adverse reactions report in relation to retirement. Anyone who experiences symptoms after the use of the product must consult with its medical care provider and inform adverse reactions to the FDA Medwatch adverse event report program, he added.
Customers with questions or those who need more information about retire
ABC News has communicated with Dermarite Industries to make comments.
